Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Balancing Weight Loss and Thyroid Health The case underscores an important message: weight loss, especially rapid weight loss from medications like tirzepatide , can have unintended consequences, particularly in patients with underlying thyroid conditions
Clinical trial data indicates that nausea is the most prevalent gastrointestinal complaint, affecting approximately 15-20% of patients, particularly during dose escalation
We also describe the development of incretin-based pharmacotherapy, starting with exendin- 4 and ending with the identification of multi-incretin hormone receptor agonists, which appear to be the next major step in the fight against T2DM and obesity
Managing Side Effects: Start with low doses and increase gradually
